Biodetection National Institute of Standards and Technology Releases H5N1 Diagnostic Validation MaterialGlobal Biodefense StaffJanuary 2, 2025
Biodetection Diagnosing Difficult-to-detect Pathogens in Central Nervous System InfectionsGlobal Biodefense StaffNovember 13, 2024
Biodetection Tools for Dealing with Radiation Exposures: IARPA Invests $3.8M from TEI-REX ProgramGlobal Biodefense StaffSeptember 3, 2024
Are We There Yet? Agent Agnostic Metagenome Sequencing for Biothreat Detection Biodetection July 31, 2024 …
Lacking Diagnostic Tools, Malaria Becomes Catch-All Diagnosis for Febrile Diseases in W. Africa Biodetection June 7, 2024 …
Scientists Close in on TB Blood Test Which Could Detect Millions of Silent Spreaders Biodetection March 22, 2024 …
BARDA Looks to Advance Metagenomic Next-Generation Sequencing (mNGS) Biodetection February 12, 2024 …
NIH Funds Continued Development of Maxim Bio’s At-Home Test for COVID and Flu Biodetection February 1, 2024 …
Maxim Biomedical Secures $49.5M Manufacturing Award from HHS to Strengthen Pandemic Testing Efforts Biodetection January 4, 2024 …
First Light Diagnostics Receives FDA Clearance for Rapid Anthrax Test Biodetection December 5, 2023 …
Inflammatix Completes Development for Acute Infection and Sepsis Test System Biodetection November 15, 2023 …
HHS Awards $600M to 12 Manufacturers to Bolster COVID-19 Test Supply Chain Biodetection September 20, 2023 …
Molecular Diagnostic Test for Six Biothreat Pathogens Receives FDA Clearance Biodetection September 19, 2023 …
